SOW
VIRX

State of Wyoming’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

State of Wyoming’s Portfolio VIRX Stock Details VIRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-599
Closed -$2K – 2059
2021
Q4 		$2K Sell
599
-5
-0.8% -$27 ﹤0.01% 1789
2021
Q3 		$5K Buy
604
+515
+579% +$5.08K ﹤0.01% 1098
2021
Q2 		$1K Buy
+89
New +$893 ﹤0.01% 1154

Other funds holding VIRX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State of Wyoming's VIRX Position: Q1 2022 in Review

State of Wyoming sold out of Viracta Therapeutics, Inc. Common Stock (VIRX) in Q1 2022, closing a stake of 599 shares — an estimated $2K sold.

State of Wyoming first reported a position in VIRX in Q2 2021 and held it in 3 quarters. The position peaked at $5K in Q3 2021. 69 funds tracked by Wall St. Rank hold VIRX as of Q1 2022.

  • State of Wyoming reported no remaining Viracta Therapeutics, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • State of Wyoming sold 599 Viracta Therapeutics, Inc. Common Stock shares in Q1 2022, an estimated $2K.
  • State of Wyoming first reported a position in Viracta Therapeutics, Inc. Common Stock in Q2 2021 and held it in 3 quarters.
  • State of Wyoming's Viracta Therapeutics, Inc. Common Stock position peaked at $5K in Q3 2021.
  • 69 funds tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q1 2022.

Based on State of Wyoming's 13F filing for Q1 2022, filed 13 May 2022.